Gene · 488
Papers3,333
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,333
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dominant rhabdomyolysis linked to a recurrent ATP2A2 variant reducing SERCA2 function in muscle. | Brain | 2025 | 39970126 | Swiss-Prot, curated | PubMed |
| Identification of therapeutic targets for Alzheimer's Disease Treatment using bioinformatics and machine learning. | Sci Rep | 2025 | 39890844 | PubTator, text mining | PubMed |
| SERCA2 dysfunction accelerates angiotensin II-induced aortic aneurysm and atherosclerosis by induction of oxidative stress in aortic smooth muscle cells. | J Mol Cell Cardiol | 2025 | 39884553 | PubTator, text mining | PubMed |
| Hypericin photoactivation induces triple-negative breast cancer cells pyroptosis by targeting the ROS/CALR/Caspase-3/GSDME pathway. | J Adv Res | 2025 | 39870303 | PubTator, text mining | PubMed |
| Effects of 8 Weeks of Moderate- or High-Volume Strength Training on Sarcoplasmic Reticulum Ca2+ Handling in Elite Female and Male Rowers. | Scand J Med Sci Sports | 2025 | 39831408 | PubTator, text mining | PubMed |
| A Homozygous ATP2A2 Variant Alters Sarcoendoplasmic Reticulum Ca2+-ATPase 2 Function in Skeletal Muscle and Causes a Novel Vacuolar Myopathy. | Neuropathol Appl Neurobiol | 2025 | 39817497 | PubTator, text mining | PubMed |
| MMFuncPhos: A Multi-Modal Learning Framework for Identifying Functional Phosphorylation Sites and Their Regulatory Types. | Adv Sci (Weinh) | 2025 | 39804866 | PubTator, text mining | PubMed |
| Darier disease: Current insights and challenges in pathogenesis and management. | J Eur Acad Dermatol Venereol | 2025 | 39606894 | PubTator, text mining | PubMed |
| A novel ATP2A2 mutation in Darier and genotype phenotype: correlation analysis. | Genes Genomics | 2025 | 39528793 | PubTator, text mining | PubMed |
| Identification of lncRNA in circulating exosomes as potential biomarkers for MCI among the elderly. | J Affect Disord | 2025 | 39528147 | PubTator, text mining | PubMed |
| Sleep deprivation stimulates adaptive thermogenesis by activating AMPK pathway in mice. | J Comp Physiol B | 2025 | 39477902 | PubTator, text mining | PubMed |
| Consolidating the Role of Mutated ATP2B2 in Neurodevelopmental and Cerebellar Pathologies. | Clin Genet | 2025 | 39367743 | PubTator, text mining | PubMed |
| Targeting SERCA2 in Anti-Tumor Drug Discovery. | Curr Drug Targets | 2025 | 39323343 | PubTator, text mining | PubMed |
| A case of Darier's disease with a missense mutation in exon 8 of ATP2A2. | J Dermatol | 2025 | 39315574 | PubTator, text mining | PubMed |
| Pumping the Breaks on Acantholytic Skin Disorders: Targeting Calcium Pumps, Desmosomes, and Downstream Signaling in Darier, Hailey-Hailey, and Grover Disease. | J Invest Dermatol | 2025 | 39207315 | PubTator, text mining | PubMed |
| Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions. | Physiol Rev | 2025 | 39115424 | PubTator, text mining | PubMed |
| A natural small molecule alleviates liver fibrosis by targeting apolipoprotein L2. | Nat Chem Biol | 2025 | 39103634 | PubTator, text mining | PubMed |
| Successful treatment of Darier's disease with apremilast and review of reported cases. | J Dermatol | 2025 | 39031325 | PubTator, text mining | PubMed |
| A novel ATP2A2 mutation in a familial case of Darier disease accompanied with intellectual disability. | J Dermatol | 2025 | 38894563 | PubTator, text mining | PubMed |
| Cardiac Tissue Engineering: A Journey from Scaffold Fabrication to In Vitro Characterization. | Small Sci | 2024 | 40212070 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/488/papers?page=6